Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Sarcoidosis complicating treatment with adalimumab for Crohn's disease.

McDonnell MJ, Rutherford RM, O'Regan A.

J Crohns Colitis. 2014 Sep;8(9):1140-1. doi: 10.1016/j.crohns.2014.02.006. Epub 2014 Mar 13. No abstract available.

PMID:
24631310
2.

Acute coronary syndrome in a Crohn's disease patient treated with adalimumab.

Petitpain N, Bornert-Keller N, Peyrin-Biroulet L.

J Crohns Colitis. 2013 Oct;7(9):e396. doi: 10.1016/j.crohns.2013.02.011. Epub 2013 Mar 21. No abstract available.

PMID:
23523265
3.

Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis.

Marcella S, Welsh B, Foley P.

Australas J Dermatol. 2011 Aug;52(3):e8-11. doi: 10.1111/j.1440-0960.2010.00660.x. Epub 2010 Jun 23.

PMID:
21834808
4.

Listeria monocytogenes infection in Crohn's disease treated with adalimumab.

Willson KJ, Jacob A, Shetti MP, Bhatia R, Yee K, Osler W.

Med J Aust. 2012 Oct 15;197(8):466-7. No abstract available.

PMID:
23072245
5.
6.

Guillain-Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: case report and literature review.

Cesarini M, Angelucci E, Foglietta T, Vernia P.

J Crohns Colitis. 2011 Dec;5(6):619-22. doi: 10.1016/j.crohns.2011.06.010. Epub 2011 Jul 28. Review.

PMID:
22115384
7.

Sarcoidosis during infliximab therapy for Crohn's disease.

Takahashi H, Kaneta K, Honma M, Ishida-Yamamoto A, Ashida T, Kohgo Y, Ohsaki Y, Iizuka H.

J Dermatol. 2010 May;37(5):471-4. doi: 10.1111/j.1346-8138.2010.00861.x.

PMID:
20536653
8.

A case of adalimumab-induced pneumonitis in a 45-year-old man with Crohn's disease.

Reid JD, Bressler B, English J.

Can Respir J. 2011 Sep-Oct;18(5):262-4.

9.

Adalimumab-induced psoriasis in a patient with Crohn's disease.

Korkmaz U, Duman AE, Dindar G, Yilmaz H, Dursun IH, Celebi A, Senturk O, Hulagu S.

Indian J Gastroenterol. 2013 Mar;32(2):135-6. doi: 10.1007/s12664-012-0281-2. No abstract available.

PMID:
23151897
10.

[Efficacy and safety of Adalimumab in Crohn's disease].

Serghini M, Haddad W, Jeddi H, Karoui S, Ben Mustapha N, Kallel L, Fekih M, Matri S, Boubaker J, Filali A.

Tunis Med. 2012 Feb;90(2):101-7. Review. French.

11.

Severe adalimumab-induced thrombocytopenia in a patient with Crohn's disease.

Casanova MJ, Chaparro M, Martínez S, Vicuña I, Gisbert JP.

J Crohns Colitis. 2012 Dec;6(10):1034-7. doi: 10.1016/j.crohns.2012.04.001. Epub 2012 Apr 23.

PMID:
22534313
12.

A case of opportunistic skin infection with Mycobacterium marinum during adalimumab treatment in a patient with Crohn's disease.

Kump PK, Högenauer C, Wenzl HH, Petritsch W.

J Crohns Colitis. 2013 Feb;7(1):e15-8. doi: 10.1016/j.crohns.2012.04.015. Epub 2012 Jul 5.

PMID:
22770648
13.

Palmoplantar pustulosis with fulminant dystrophic 20-nail psoriasis in a patient receiving adalimumab therapy.

Mishra V, Daniel RC, Elmets CA, Levin A, Elewski BE.

J Drugs Dermatol. 2013 Jan;12(1):16-7. No abstract available.

14.

Adalimumab reversed a severe lymphopenia in a patient with Crohn's disease.

Taxonera C, Mendoza JL, Ortega L, Pérez MI, Díaz-Rubio M.

J Crohns Colitis. 2012 May;6(4):488-91. doi: 10.1016/j.crohns.2011.10.016. Epub 2011 Dec 14.

PMID:
22398051
15.

Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.

Haennig A, Bonnet D, Thebault S, Alric L.

Gastroenterol Clin Biol. 2010 Sep;34(8-9):e7-8. doi: 10.1016/j.gcb.2010.01.016. Epub 2010 Feb 26. No abstract available.

16.

Treating Crohn's disease: at "deep" remission and exploring beyond.

Corte C, Selby WS.

Med J Aust. 2012 Oct 15;197(8):430-1. No abstract available.

PMID:
23072227
17.

TNF-α inhibitor (adalimumab) induced psoriasis: a case report.

Al-Mutairi A, Elkashlan M, Al-Fayed HM, Swayed M.

Australas J Dermatol. 2012 May;53(2):157. doi: 10.1111/j.1440-0960.2012.00890.x. No abstract available.

PMID:
22571571
18.

Successfully multiple pregnancies in Crohn's disease under long-term treatment with adalimumab.

Tursi A.

Acta Gastroenterol Belg. 2013 Jun;76(2):264-5. No abstract available.

PMID:
23898572
19.

Hodgkin lymphoma following adalimumab for the treatment of Crohn's disease in an adolescent.

Rodriguez AA, Kerner J, Luna-Fineman S, Berry GJ.

Dig Dis Sci. 2014 Oct;59(10):2403-5. doi: 10.1007/s10620-014-3191-6. No abstract available.

PMID:
24817339
20.

Commentary: infliximab or adalimumab in Crohn's disease?

Sprakes MB, Hamlin PJ.

Aliment Pharmacol Ther. 2012 Aug;36(4):398. doi: 10.1111/j.1365-2036.2012.05167.x. No abstract available.

Supplemental Content

Support Center